Stenocare A/S

Equities

STENO

DK0061078425

Pharmaceuticals

Delayed Nasdaq Copenhagen 10:07:12 2024-04-26 am EDT 5-day change 1st Jan Change
5.06 DKK +1.40% Intraday chart for Stenocare A/S -3.07% +99.21%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Stenocare A/S Announces That the New STENOCARETHC/CBD Medical Cannabis Oil Product Available for Sale in Denmark CI
Stenocare A/S to Deliver New Medical Cannabis Oil Product for Australian Patients CI
Stenocare Gets Nod for Sale of Medical Cannabis Oil Product in Denmark MT
STENOCARE Receives Approval to Sell a New Medical Cannabis Oil Product in Denmark CI
Stenocare A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Stenocare A/S Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Danish Medical Cannabis Group Stenocare Secures Refinancing Deal MT
Stenocare A/S Reaches Refinancing Agreement Covering All Existing Debt of DKK 8.2 Million CI
Stenocare Aims to Boost Sales in Australia via Quest Biotech Pharma Team up MT
Stenocare A/S Enters into A New Partnership Agreement with Quest Biotech Pharma CI
Stenocare A/S Expands Presence with New Medical Cannabis Oil Product CI
Stenocare A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Stenocare to Supply, Sell Medical Cannabis in Germany; Shares Surge MT
Stenocare Ready to Ship Medical Cannabis to German Patients CI
Stenocare A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Stenocare A/S Provides Sales Guidance for the Year 2023 CI
Stenocare A/S Provides Update on Their Strong Danish Product Pipeline CI
Stenocare A/S Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Stenocare Raises DKK10.7 Million from Oversubscribed Rights Offering; Falls 10% MT
Denmark’s Stenocare Teams Up with International Partner for New Cannabis Oil Product MT
Stenocare A/S Reports on Significant Progress in Development of Its New Innovative Medical Cannabis Product CI
Stenocare A/S Launches IT-Platform for Online Clinics CI
Denmark's Stenocare Wins Regulatory Nod to Enter German Market MT
Stenocare A/S Expands into Germany with Local Partner, ADREX Pharma CI
Stenocare A/S Auditor Raises 'Going Concern' Doubt CI
Chart Stenocare A/S
More charts
STENOCARE A/S is a Denmark-based company, which is engaged in the production of medical cannabis products to patients. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The Company distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. STENO Stock
  4. News Stenocare A/S
  5. Stenocare A/S : Completes Large-scale Cannabis Cultivation Facility